Staring down IP theft lawsuit, synthetic biology company seeks $86M IPO
October 04, 2018 at 09:35 AM EDT
Backed by Illumina, the synthetic biology company is a rarity among life sciences IPOs: It has revenue. It also is in the middle of a potentially big lawsuit with Agilent and has a unique deal with Microsoft.
